Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Cervical Cancer

  Free Subscription


1 ACS Appl Mater Interfaces
1 Acta Cytol
1 Acta Obstet Gynecol Scand
1 Adv Cancer Res
1 Am J Clin Pathol
1 Ann Epidemiol
1 Anticancer Res
2 Asian Pac J Cancer Prev
1 BMC Cancer
1 BMC Womens Health
1 BMJ Open
1 Br J Cancer
1 Brachytherapy
1 Clin Transl Oncol
1 EBioMedicine
1 Eur J Pharmacol
1 Exp Cell Res
1 Fertil Steril
1 Front Oncol
1 Front Pharmacol
1 Gynecol Obstet Fertil Senol
1 Int J Clin Oncol
3 Int J Environ Res Public Health
1 Int J Equity Health
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
2 Int J Mol Sci
1 J Biochem
2 J Cancer
5 J Low Genit Tract Dis
1 J Mater Chem B
1 J Med Internet Res
1 J Natl Cancer Inst
1 J Obstet Gynaecol Res
1 J Reprod Immunol
1 J Womens Health (Larchmt)
1 JAMA Netw Open
1 Lancet Public Health
1 Med J Aust
2 Molecules
1 Obstet Gynecol
1 Oncol Lett
2 Panminerva Med
1 Pathog Dis
1 PLoS One
1 Prev Med
1 Rev Saude Publica
1 Sci Rep
1 Sichuan Da Xue Xue Bao Yi Xue Ban
1 Support Care Cancer
1 Trop Med Int Health
1 Turk J Obstet Gynecol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    ACS Appl Mater Interfaces

  1. WENZEL T, Carvajal Berrio DA, Daum R, Reisenauer C, et al
    Molecular Effects and Tissue Penetration Depth of Physical Plasma in Human Mucosa Analyzed by Contact- and Marker-Independent Raman Microspectroscopy.
    ACS Appl Mater Interfaces. 2019;11:42885-42895.
    PubMed         Abstract available

    Acta Cytol

  2. LEITE KRM, Pimenta R, Canavez J, Canavez F, et al
    HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.
    Acta Cytol. 2020 Apr 1:1-5. doi: 10.1159/000506725.
    PubMed         Abstract available

    Acta Obstet Gynecol Scand

  3. VISTAD I, Lindemann K, Bentzen AG, Dahl AA, et al
    Preferences for follow-up in long-term survivors after cervical cancer.
    Acta Obstet Gynecol Scand. 2020 Mar 30. doi: 10.1111/aogs.13855.
    PubMed         Abstract available

    Adv Cancer Res

  4. FORD ME, Cannady K, Nahhas GJ, Knight KD, et al
    Assessing an intervention to increase knowledge related to cervical cancer and the HPV vaccine.
    Adv Cancer Res. 2020;146:115-137.
    PubMed         Abstract available

    Am J Clin Pathol

  5. MORRIS CP, Chowsilpa S, Mustafa S, Chan I, et al
    Impact of the Current US Preventive Services Task Force Recommendations for Cervical Cancer Screening in Young Women 21 to 29 Years Old.
    Am J Clin Pathol. 2020 Mar 28. pii: 5812988. doi: 10.1093.
    PubMed         Abstract available

    Ann Epidemiol

  6. YANG Z, Hou Y, Lyu J, Liu D, et al
    Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach.
    Ann Epidemiol. 2020 Mar 4. pii: S1047-2797(19)30442.
    PubMed         Abstract available

    Anticancer Res

  7. MEKURIA S, Jerkeman M, Forslund O, Fikru S, et al
    Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women.
    Anticancer Res. 2020;40:1513-1517.
    PubMed         Abstract available

    Asian Pac J Cancer Prev

  8. ANGGRAENI TD, Rustamadji P, Aziz MF
    Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer.
    Asian Pac J Cancer Prev. 2020;21:831-835.
    PubMed         Abstract available

  9. ROMLI R, Shahabudin S, Saddki N, Mokhtar N, et al
    Effectiveness of a Health Education Program to Improve Knowledge and Attitude Towards Cervical Cancer and Pap Smear: A Controlled Community Trial in Malaysia.
    Asian Pac J Cancer Prev. 2020;21:853-859.
    PubMed         Abstract available

    BMC Cancer

  10. ZHANG Y, Na R, Wang X
    LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells.
    BMC Cancer. 2019;19:1052.
    PubMed         Abstract available

    BMC Womens Health

  11. BAKIEWICZ A, Rasch V, Mwaiselage J, Linde DS, et al
    "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    BMC Womens Health. 2020;20:65.
    PubMed         Abstract available

    BMJ Open

  12. GOLDSTEIN A, Goldstein LS, Lipson R, Bedell S, et al
    Assessing the feasibility of a rapid, high-volume cervical cancer screening programme using HPV self-sampling and digital colposcopy in rural regions of Yunnan, China.
    BMJ Open. 2020;10:e035153.
    PubMed         Abstract available

    Br J Cancer

  13. HASHIM D, Engesaeter B, Baadstrand Skare G, Castle PE, et al
    Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
    Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0790.
    PubMed         Abstract available


  14. LOMBE D, Crook J, Bachand F, Moore J, et al
    The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
    Brachytherapy. 2020 Mar 28. pii: S1538-4721(20)30014.
    PubMed         Abstract available

    Clin Transl Oncol

  15. PUCHAR A, Boudy AS, Selleret L, Arfi A, et al
    Invasive and in situ cervical cancer associated with pregnancy: analysis from the French cancer network (CALG: Cancer Associe a La Grossesse).
    Clin Transl Oncol. 2020 Apr 2. pii: 10.1007/s12094-020-02343.
    PubMed         Abstract available


  16. HATT M, Lucia F, Schick U, Visvikis D, et al
    Multicentric validation of radiomics findings: challenges and opportunities.
    EBioMedicine. 2019;47:20-21.

    Eur J Pharmacol

  17. SHARIFI S, Mostafavi PG, Tarasi R, Moradi AM, et al
    Purified compounds from marine organism sea pen induce apoptosis in human breast cancer cell MDA-MB-231 and cervical cancer cell Hela.
    Eur J Pharmacol. 2020 Mar 25:173075. doi: 10.1016/j.ejphar.2020.173075.
    PubMed         Abstract available

    Exp Cell Res

  18. CHEN HC, Rui W, You SY, Liu XW, et al
    Evaluation of the anti-cervical cancer effect of a prodrug CBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models.
    Exp Cell Res. 2020 Mar 27:111980. doi: 10.1016/j.yexcr.2020.111980.
    PubMed         Abstract available

    Fertil Steril

  19. NEZHAT C, Roman RA, Rambhatla A, Nezhat F, et al
    Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review.
    Fertil Steril. 2020;113:685-703.
    PubMed         Abstract available

    Front Oncol

  20. CLEMENTE-PERIVAN SI, Gomez-Gomez Y, Leyva-Vazquez MA, Lagunas-Martinez A, et al
    Role of Oct3/4 in Cervical Cancer Tumorigenesis.
    Front Oncol. 2020;10:247.
    PubMed         Abstract available

    Front Pharmacol

  21. YOU Y, He Q, Lu H, Zhou X, et al
    Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer.
    Front Pharmacol. 2020;11:271.
    PubMed         Abstract available

    Gynecol Obstet Fertil Senol

  22. GONTHIER C, Desportes C, Pretet JL, Azais H, et al
    [HPV testing in the screening and follow-up of patients with cervical high-grade squamous intraepithelial lesions].
    Gynecol Obstet Fertil Senol. 2019;47:747-752.
    PubMed         Abstract available

    Int J Clin Oncol

  23. GE J, Sun J, Li J, Zhang Q, et al
    Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.
    Int J Clin Oncol. 2020 Mar 31. pii: 10.1007/s10147-019-01585.
    PubMed         Abstract available

    Int J Environ Res Public Health

  24. VILLANUEVA S, Mosteiro-Miguens DG, Dominguez-Martis EM, Lopez-Ares D, et al
    Knowledge, Attitudes, and Intentions towards Human Papillomavirus Vaccination among Nursing Students in Spain.
    Int J Environ Res Public Health. 2019;16.
    PubMed         Abstract available

  25. KRIAUCIONIENE V, Petkeviciene J
    Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.
    Int J Environ Res Public Health. 2019;16.
    PubMed         Abstract available

  26. MARTINELLI M, Musumeci R, Sechi I, Sotgiu G, et al
    Prevalence of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs) among Italian Women Referred for a Colposcopy.
    Int J Environ Res Public Health. 2019;16.
    PubMed         Abstract available

    Int J Equity Health

  27. MAHUMUD RA, Keramat SA, Ormsby GM, Sultana M, et al
    Wealth-related inequalities of women's knowledge of cervical cancer screening and service utilisation in 18 resource-constrained countries: evidence from a pooled decomposition analysis.
    Int J Equity Health. 2020;19:42.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  28. KEHOE S, Bhatla N
    FIGO stage IIB cervical cancer prognostication in low-resource settings.
    Int J Gynaecol Obstet. 2020 Apr 3. doi: 10.1002/ijgo.13138.

    Int J Gynecol Cancer

  29. SALVO G, Odetto D, Pareja R, Frumovitz M, et al
    Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain.
    Int J Gynecol Cancer. 2020 Apr 1. pii: ijgc-2020-001257.
    PubMed         Abstract available

    Int J Mol Sci

  30. BANERJEE NS, Moore D, Parker CJ, Broker TR, et al
    Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
    Int J Mol Sci. 2019;20.
    PubMed         Abstract available

  31. KAGABU M, Nagasawa T, Sato C, Fukagawa Y, et al
    Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

    J Biochem

  32. ZHANG L, Ge S, Cao B
    Long non-coding RNA MIAT promotes cervical cancer proliferation and migration.
    J Biochem. 2020 Apr 1. pii: 5814929. doi: 10.1093.
    PubMed         Abstract available

    J Cancer

  33. CAO Y, Han Q, Li J, Jia Y, et al
    P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition.
    J Cancer. 2020;11:2788-2799.
    PubMed         Abstract available

  34. XIE Q, Ou-Yang W, Zhang M, Wang H, et al
    Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
    J Cancer. 2020;11:2852-2863.
    PubMed         Abstract available

    J Low Genit Tract Dis

  35. PERKINS RB, Guido RS, Castle PE, Chelmow D, et al
    2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    J Low Genit Tract Dis. 2020;24:102-131.

  36. PRETORIUS RG, Belinson JL, Peterson P
    Loop Electrosurgical Excision Procedure or Cervical Conization to Exclude Cervical Cancer Before Simple Hysterectomy.
    J Low Genit Tract Dis. 2020;24:202-205.
    PubMed         Abstract available

  37. CLARKE MA, Darragh TM, Nelson E, Unger ER, et al
    Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management.
    J Low Genit Tract Dis. 2020;24:157-166.
    PubMed         Abstract available

  38. PERKINS RB, Fuzzell LN, Lake P, McIntyre M, et al
    Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests.
    J Low Genit Tract Dis. 2020;24:167-177.
    PubMed         Abstract available

  39. CLARKE MA, Massad LS, Khan MJ, Smith KM, et al
    Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective.
    J Low Genit Tract Dis. 2020;24:184-191.
    PubMed         Abstract available

    J Mater Chem B

  40. LUO L, Zeng F, Xie J, Fan J, et al
    A RBC membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of cervical cancer.
    J Mater Chem B. 2020 Apr 2. doi: 10.1039/c9tb02937.
    PubMed         Abstract available

    J Med Internet Res

  41. LINDE DS, Andersen MS, Mwaiselage J, Manongi R, et al
    Effectiveness of One-Way Text Messaging on Attendance to Follow-Up Cervical Cancer Screening Among Human Papillomavirus-Positive Tanzanian Women (Connected2Care): Parallel-Group Randomized Controlled Trial.
    J Med Internet Res. 2020;22:e15863.
    PubMed         Abstract available

    J Natl Cancer Inst

  42. HARKENRIDER MM, Markham MJ, Dizon DS, Jhingran A, et al
    Moving Forward in Cervical Cancer - Enhancing Susceptibility to DNA Repair Inhibition and Damage: NCI Clinical Trials Planning Meeting Report.
    J Natl Cancer Inst. 2020 Mar 27. pii: 5812785. doi: 10.1093.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  43. HASHIGUCHI M, Masuda M, Kai K, Nakao Y, et al
    Decreased cytokeratin 7 expression correlates with the progression of cervical squamous cell carcinoma and poor patient outcomes.
    J Obstet Gynaecol Res. 2019;45:2228-2236.
    PubMed         Abstract available

    J Reprod Immunol

  44. LIU F, Chang L, Hu J
    Activating transcription factor 6 regulated cell growth, migration and inhibiteds cell apoptosis and autophagy via MAPK pathway in cervical cancer.
    J Reprod Immunol. 2020;139:103120.
    PubMed         Abstract available

    J Womens Health (Larchmt)

  45. ROHNER E, McGuire FH, Liu Y, Li Q, et al
    Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
    J Womens Health (Larchmt). 2020 Mar 26. doi: 10.1089/jwh.2019.8132.
    PubMed         Abstract available

    JAMA Netw Open

  46. MOEN KA, Kumar B, Igland J, Diaz E, et al
    Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
    JAMA Netw Open. 2020;3:e201903.
    PubMed         Abstract available

    Lancet Public Health

    Japan's HPV vaccine crisis: act now to avert cervical cancer cases and deaths.
    Lancet Public Health. 2020;5:e184-e185.

    Med J Aust

  48. BROTHERTON JM, Budd AC, Saville M
    Understanding the proportion of cervical cancers attributable to HPV.
    Med J Aust. 2020;212:63-64.


  49. FATHY M, Fawzy MA, Hintzsche H, Nikaido T, et al
    Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.
    Molecules. 2019;24.
    PubMed         Abstract available

  50. BALHAMAR SOMS, Panicker NG, Akhlaq S, Qureshi MM, et al
    Differential Cytotoxic Potential of Acridocarpus orientalis Leaf and Stem Extracts with the Ability to Induce Multiple Cell Death Pathways.
    Molecules. 2019;24.
    PubMed         Abstract available

    Obstet Gynecol

  51. WONG H, Dwarica D, Quiroz L
    Novel Use of Three-Dimensional Ultrasonography to Locate a Retained Needle in the Vaginal Wall.
    Obstet Gynecol. 2019;134:1282-1284.
    PubMed         Abstract available

    Oncol Lett

  52. LU F, Cui D, Mu B, Zhao L, et al
    Downregulation of TMOD1 promotes cell motility and cell proliferation in cervical cancer cells.
    Oncol Lett. 2020;19:3339-3348.
    PubMed         Abstract available

    Panminerva Med

  53. ZHONG W, Zhao C, He X, Li Z, et al
    Inhibition of has-miRNA-95 expression can improve the radiosensitivity of cervical cancer cells.
    Panminerva Med. 2020 Mar 30. pii: S0031-0808.20.03899.

  54. GE J, Ge X, Li H
    Resveratrol inhibits Treg/Th17 mediated tumor immune escape in mice with cervical cancer.
    Panminerva Med. 2020 Mar 30. pii: S0031-0808.20.03900.

    Pathog Dis

  55. SU J, Ma J, Mo F, Yang X, et al
    Thermosensitive hydrogels as a controlled release system for alkannin to improve localized treatment of Candida vaginitis after external beam radiotherapy in vitro and in vivo.
    Pathog Dis. 2019;77.
    PubMed         Abstract available

    PLoS One

  56. NEJO YT, Olaleye DO, Odaibo GN
    Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.
    PLoS One. 2019;14:e0224748.
    PubMed         Abstract available

    Prev Med

  57. CONNOLLY D, Hughes X, Berner A
    Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review.
    Prev Med. 2020 Mar 31:106071. doi: 10.1016/j.ypmed.2020.106071.
    PubMed         Abstract available

    Rev Saude Publica

  58. HURTADO-ROCA Y, Becerra-Chauca N, Malca M
    Efficacy and safety of cryotherapy, cold cone or thermocoagulation compared to LEEP as a therapy for cervical intraepithelial neoplasia: Systematic review.
    Rev Saude Publica. 2020;54:27.
    PubMed         Abstract available

    Sci Rep

  59. KARIMI H, Soleimanjahi H, Abdoli A, Banijamali RS, et al
    Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer.
    Sci Rep. 2020;10:5787.
    PubMed         Abstract available

    Sichuan Da Xue Xue Bao Yi Xue Ban

  60. RAN W, Zeng YH, Ma XJ, Liao P, et al
    [The Effect of miR-503-5p on the Proliferation, Invasion, Migration and Epithelial Interstitium of Cervical Cancer HeLa Cells via Targeting E2 F3].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51:178-184.
    PubMed         Abstract available

    Support Care Cancer

  61. DO ROSARIO RAMOS NUNES BACALHA, Pedras S, da Graca Pereira Alves M
    Attachment style and body image as mediators between marital adjustment and sexual satisfaction in women with cervical cancer.
    Support Care Cancer. 2020 Apr 1. pii: 10.1007/s00520-020-05423.
    PubMed         Abstract available

    Trop Med Int Health

  62. BUNYA KAMIZA A, Kamiza S, Gideon Singini M, George Mathew C, et al
    Association of TP53 rs1042522 with cervical cancer in sub-Saharan Africa population: a meta-analysis.
    Trop Med Int Health. 2020 Mar 31. doi: 10.1111/tmi.13397.
    PubMed         Abstract available

    Turk J Obstet Gynecol

  63. CAKIR C, Yuksel D, Kilic C, Unsal M, et al
    Bone recurrence after radical hysterectomy and lymphadenectomy in early-stage cervical cancer.
    Turk J Obstet Gynecol. 2019;16:266-270.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.